Investor Lansdowne Partners Limited Partnership
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Lansdowne Partners Limited Partnership . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2014-02-14 13G/A CYTK / Cytokinetics, Incorporated 2,547,227
2014-02-14 13G/A DATA / Tableau Software, Inc. 975,000
2014-02-14 13G/A RGDXQ / Response Genetics, Inc 3,805,161
2014-02-14 13G/A MANU / Manchester United plc 2,731,445
2013-11-18 13G DATA / Tableau Software, Inc. 575,000
2013-02-14 13G/A CYTK / Cytokinetics, Incorporated 13,567,083
2013-02-14 13G/A RGDXQ / Response Genetics, Inc 3,805,161
2013-02-14 13G/A MDVN / Medivation, Inc. 0
2013-02-14 13G MANU / Manchester United plc 2,421,434
2012-04-12 13G/A CYTK / Cytokinetics, Incorporated 4,322,680
2012-02-13 13G/A MDVN / Medivation, Inc. 1,875,773
2012-02-13 13G/A RGDXQ / Response Genetics, Inc 3,905,676
2012-02-13 13G/A CYTK / Cytokinetics, Incorporated 4,322,680